eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences. Each of eFFECTOR’s product candidates is designed to act on a single protein that regulates, in a coordinated manner, the expression of multiple functionally related proteins that together drive important biological processes such as immune evasion, stress and inflammatory responses, as well as cell proliferation.
View Top Employees from eFFECTOR Therapeutics, Inc.Website | http://effector.com |
Ticker | EFTR |
Revenue | $3 million |
Employees | 27 (16 on RocketReach) |
Founded | 2012 |
Address | 142 North Cedros Ave Suite B, Solana Beach, California 92075, US |
Phone | (858) 925-8215 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Biotechnology, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Medical |
Web Rank | 12 Million |
Keywords | Effector, Stephen Worland |
Competitors | BerGenBio ASA, Centrose LLC, Karus Therapeutics Limited, TARIS Bio |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541711 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular eFFECTOR Therapeutics, Inc. employee's phone or email?
The eFFECTOR Therapeutics, Inc. annual revenue was $3 million in 2024.
Michael Byrnes is the CFO of eFFECTOR Therapeutics, Inc..
16 people are employed at eFFECTOR Therapeutics, Inc..
eFFECTOR Therapeutics, Inc. is based in Solana Beach, California.
The NAICS codes for eFFECTOR Therapeutics, Inc. are [541711, 32, 541, 325, 54171, 54, 5417].
The SIC codes for eFFECTOR Therapeutics, Inc. are [28, 283].